How oncology pharmacy leaders fight burnout with stay surveys, smarter schedules, and recognition—building resilient teams through loss and turnover.
Publication|Articles|October 13, 2026
Pharmacy Practice in Focus: Oncology
- October 2026
- Volume 8
- Issue 7
Breast Cancer Is Becoming an At-Home, Long-Haul Disease: Pharmacists as Primary Points of Contact
Fact checked by: Ron Panarotti
At-home chemotherapy for HR+ breast cancer works best when pharmacists guide oral regimens, boosting adherence, safety, and affordable access.
Advertisement
Advertisement
Breast cancer is the most common malignancy in women in the United States, with approximately 75% of cases being hormone receptor–positive (HR+) disease requiring long-term, oral, endocrine- based treatment in early and advanced stages.1 Treatment of HR+ early-stage breast cancer (eBC) involves 5 to 10 years of endocrine therapy (ET) with or without oral targeted therapies, such as a CDK4/6 inhibitor for 2 to 3 years and/or 1 year of a PARP inhibitor.2
Related to this article
Managing medication safety in specialized populations requires a shift from standardized dosing to precise, patient-specific customization.
Sometimes, a breakthrough matters not only because of what it does for patients today, but because of what it makes possible for tomorrow.
Pharmacogenomic-guided prescribing uses genetic data to protect patients from dangerous toxicities and get them the right drug at the right dose from the start.
As accessible health care providers, pharmacists can raise awareness about the proper use of OTC blood glucose meters and continuous glucose monitoring devices.
Growing evidence points to gallstones and cholecystitis as an underrecognized risk of GLP-1 RA therapy—pharmacists are well positioned to catch it early.
As earning years peak, so do spending and responsibility—here’s where midcareer pharmacists should focus their financial decision-making.
Despite the controversy surrounding mRNA's role in the COVID-19 response, the technology's broader promise—to prevent, treat, and even cure a host of diseases—is coming into focus.
Advertisement
Advertisement